Benzinga's Top #PreMarket Gainers
November 25, 2015 at 08:07 AM EST
KaloBios Pharmaceuticals Inc (NASDAQ: KBIO) shares rose 15 percent to $21.16 in pre-market trading after dropping 53.42 percent on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.